Jefferies Financial Group upgraded shares of Koninklijke Philips (NYSE:PHG – Free Report) from an underperform rating to a hold rating in a research note issued to investors on Tuesday morning, MarketBeat Ratings reports.
Separately, StockNews.com raised Koninklijke Philips from a “hold” rating to a “buy” rating in a report on Monday, July 15th. Four equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold”.
Koninklijke Philips Stock Down 0.4 %
Koninklijke Philips (NYSE:PHG – Get Free Report) last released its quarterly earnings results on Monday, July 29th. The technology company reported $0.32 earnings per share (EPS) for the quarter. The firm had revenue of $4.80 billion for the quarter. Koninklijke Philips had a positive return on equity of 10.15% and a negative net margin of 2.35%. Sell-side analysts predict that Koninklijke Philips will post 1.59 EPS for the current year.
Institutional Inflows and Outflows
Several large investors have recently added to or reduced their stakes in PHG. Allspring Global Investments Holdings LLC purchased a new stake in Koninklijke Philips in the 1st quarter valued at approximately $40,000. Fairscale Capital LLC acquired a new stake in shares of Koninklijke Philips in the 2nd quarter valued at approximately $54,000. CWM LLC boosted its stake in shares of Koninklijke Philips by 21.9% in the second quarter. CWM LLC now owns 3,429 shares of the technology company’s stock valued at $86,000 after buying an additional 616 shares in the last quarter. Eastern Bank acquired a new position in Koninklijke Philips during the third quarter worth $88,000. Finally, Headlands Technologies LLC purchased a new position in Koninklijke Philips in the first quarter worth $91,000. 13.67% of the stock is owned by hedge funds and other institutional investors.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Read More
- Five stocks we like better than Koninklijke Philips
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- Most active stocks: Dollar volume vs share volume
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Russell 2000 Index, How Investors Use it For Profitable Trading
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.